SMC021A - absorption, efficacy and tolerance in patients with osteoarthritis. A placebo-controlled 14-days study
Phase of Trial: Phase I
Latest Information Update: 27 Jan 2012
At a glance
- Drugs Calcitonin (Primary)
- Indications Osteoarthritis
- Focus Pharmacodynamics; Pharmacokinetics
- Sponsors Nordic Bioscience
- 10 Jun 2017 Biomarkers information updated
- 01 Feb 2010 Results published in Osteoarthritis and Cartilage.
- 16 Oct 2009 Results were reported in an Emisphere Technologies media release.